ATE496120T1 - Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit - Google Patents
Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheitInfo
- Publication number
- ATE496120T1 ATE496120T1 AT02728354T AT02728354T ATE496120T1 AT E496120 T1 ATE496120 T1 AT E496120T1 AT 02728354 T AT02728354 T AT 02728354T AT 02728354 T AT02728354 T AT 02728354T AT E496120 T1 ATE496120 T1 AT E496120T1
- Authority
- AT
- Austria
- Prior art keywords
- adenovirus
- lysis
- concentration
- same process
- process unit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
- C12N1/066—Lysis of microorganisms by physical methods
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27203401P | 2001-03-01 | 2001-03-01 | |
PCT/US2002/005596 WO2002070673A1 (en) | 2001-03-01 | 2002-02-27 | Concentration and lysis of adenovirus-infected cells in a single unit operations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496120T1 true ATE496120T1 (de) | 2011-02-15 |
Family
ID=23038121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02728354T ATE496120T1 (de) | 2001-03-01 | 2002-02-27 | Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit |
Country Status (10)
Country | Link |
---|---|
US (1) | US6773909B2 (de) |
EP (1) | EP1363997B1 (de) |
JP (2) | JP4559026B2 (de) |
AR (1) | AR032921A1 (de) |
AT (1) | ATE496120T1 (de) |
DE (1) | DE60238970D1 (de) |
ES (1) | ES2355065T3 (de) |
PE (1) | PE20020960A1 (de) |
UY (1) | UY27191A1 (de) |
WO (1) | WO2002070673A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1780269T3 (da) | 2004-02-23 | 2009-10-12 | Crucell Holland Bv | Virusrensningsmetoder |
US7592139B2 (en) * | 2004-09-24 | 2009-09-22 | Sandia National Laboratories | High temperature flow-through device for rapid solubilization and analysis |
DE602006003420D1 (de) | 2005-04-11 | 2008-12-11 | Crucell Holland Bv | Virusreinigung mit ultrafiltration |
US20100216657A1 (en) * | 2006-05-16 | 2010-08-26 | Arcxis Biotechnologies, Inc. | Pcr-free sample preparation and detection systems for high speed biologic analysis and identification |
US20080194006A1 (en) * | 2007-02-08 | 2008-08-14 | Embrex, Inc. | Methods of releasing sporocysts from oocysts using controlled shear forces |
CN114176049B (zh) * | 2022-01-20 | 2023-01-31 | 河南农业大学 | 一种同时提高室内繁育棉铃虫齿唇姬蜂出蜂率和雌虫数量的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721120A (en) * | 1996-10-02 | 1998-02-24 | Merck & Co., Inc. | Method of disrupting cultured cells using an impinging jet device |
-
2002
- 2002-02-27 DE DE60238970T patent/DE60238970D1/de not_active Expired - Lifetime
- 2002-02-27 JP JP2002570700A patent/JP4559026B2/ja not_active Expired - Fee Related
- 2002-02-27 AT AT02728354T patent/ATE496120T1/de not_active IP Right Cessation
- 2002-02-27 EP EP02728354A patent/EP1363997B1/de not_active Expired - Lifetime
- 2002-02-27 ES ES02728354T patent/ES2355065T3/es not_active Expired - Lifetime
- 2002-02-27 WO PCT/US2002/005596 patent/WO2002070673A1/en active Application Filing
- 2002-02-28 UY UY27191A patent/UY27191A1/es not_active Application Discontinuation
- 2002-02-28 AR ARP020100733A patent/AR032921A1/es unknown
- 2002-03-01 US US10/085,029 patent/US6773909B2/en not_active Expired - Fee Related
- 2002-03-01 PE PE2002000171A patent/PE20020960A1/es not_active Application Discontinuation
-
2009
- 2009-05-13 JP JP2009116744A patent/JP2009189370A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1363997B1 (de) | 2011-01-19 |
JP2009189370A (ja) | 2009-08-27 |
DE60238970D1 (de) | 2011-03-03 |
WO2002070673A1 (en) | 2002-09-12 |
JP2004533814A (ja) | 2004-11-11 |
JP4559026B2 (ja) | 2010-10-06 |
PE20020960A1 (es) | 2002-11-14 |
US6773909B2 (en) | 2004-08-10 |
ES2355065T3 (es) | 2011-03-22 |
AR032921A1 (es) | 2003-12-03 |
UY27191A1 (es) | 2002-10-31 |
EP1363997A1 (de) | 2003-11-26 |
US20030049829A1 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1152714A1 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1 | |
AU2003243151A8 (en) | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer | |
EP1537140A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 161p2f10b | |
DE60329983D1 (de) | Wachsestersynthase-dna-sequenz, protein und verwendungen davon | |
DE60222671D1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
DE60134866D1 (de) | Verwendung von imidazochinolinaminen als adjuvantien in dna-impfung | |
WO2003087306A8 (en) | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer | |
AU2003234323A1 (en) | Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis | |
EP1578366A4 (de) | Moleküle, die bevorzugt miteffektor-t-zellen oder regulatorischen t-zellen assoziiert sind undanwendungsverfahren dafür | |
DE502004000891D1 (de) | Organosilylfunktionalisierte partikel und deren herstellung | |
EP1517606A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 193p1e1b | |
PT1537140E (pt) | Ácido nucleico e proteína correspondente designada 161p2f10b úteis no tratamento e detecção de cancro | |
ATE496120T1 (de) | Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit | |
AU2002257050A1 (en) | Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer | |
DE69931255D1 (de) | In antheren und pollen exprimierte promotorsequenzen | |
IL141539A0 (en) | Dna molecules and cells transfected therewith | |
EP1425289A4 (de) | Neue nukleinsäure- und polypeptidmoleküle | |
EP1409710A4 (de) | Nukleinsäure und dieser entsprechendes, 161p5c5 genanntes, für die behandlung und den nachweis von krebs geeignetes protein | |
DE602004002601D1 (de) | Erkennung von Multiplexern und Austausch von Parametern | |
BR0212523A2 (pt) | Ácido nucléico, polipeptídeo purificado e seus usos | |
DE602004005748D1 (de) | Nitrooxy-derivate von carvedilol und anderen betablockern als antihypertensiva | |
DE60309255D1 (de) | Abbildung und Entnahme von Gel | |
IL158860A0 (en) | Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same | |
EP1565200A4 (de) | NUKLEINSûURE ENTSPRECHENDES PROTEIN 24P4C12 ZUR BEHANDLUNG UND ERKENNUNG VON KREBS | |
EP1578980A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und entsprechendes protein mit der bezeichnung 213p1f11 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |